Digital interventions for stress management in breast cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial invites breast cancer patients to participate in a randomized trial assessing two digital interventions aimed at managing stress: cognitive based stress management (CBSM) and mindfulness based intervention (MBI). Participants will first complete a health-related quality of life (HRQoL) assessment before being randomly assigned to one of the intervention groups or a control group. The study aims to evaluate the effectiveness of these digital interventions in reducing stress levels and improving HRQoL among breast cancer patients compared to the control group.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* first occurrence breast cancer diagnosed from Jan 1, 2020
* non-metastatic cancer stage 0-III

Invasive tumors must be:

* HER2 positive (regardless of ER, PR) or
* ER negative
* (may later include other ER+ if not conflict with recruitment for EMIT/OPTIMA)

Exclusion Criteria:

* None

Where it's running

• Cancer Registry of Norway
  Oslo, Norway Recruiting

Study contacts

• Principal investigator: Giske Ursin, MD, PhD — Norwegian Institute of Public Health
• Study coordinator: Giske Ursin, MD, PhD
• Email: giske.ursin@kreftregisteret.no
• Phone: +4722451300

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pro-resolving lipid mediators in postmenopausal women with and without breast cancer

  This project will test whether levels of certain inflammation-resolving fats made from dietary fatty acids differ between postmenopausal women with or without breast cancer and with or without overweight.

  Recruiting at 2 sites Clinica Universidad de Navarra, Universidad de Navarra · Pamplona, Navarre and 1 other locations · NCT07447440

• Post-treatment care program for breast and prostate cancer survivors

  This program tests whether a focused questionnaire plus quality-of-life screening can detect and help manage side effects in people who have finished curative treatment for breast or prostate cancer.

  Recruiting Masaryk Memorial Cancer Institute · Brno · NCT07253987

• Breast biomechanics and bra support after surgery and radiotherapy.

  We will test whether 3D scans and sensors can measure how surgery with or without radiotherapy changes breast movement and bra support needs in women treated for unilateral breast cancer.

  Recruiting Portsmouth Hospitals NHS Trust · Portsmouth · NCT07135960

• One-stage prepectoral implant versus two-stage expander-to-implant breast reconstruction after mastectomy and radiotherapy

  This compares immediate one-stage prepectoral implant reconstruction with two-stage expander-to-implant reconstruction in women who will have radiotherapy after mastectomy to see if one approach gives better quality of life and fewer complications.

  Recruiting Henan Cancer Hospital · Henan, Henan · NCT07037576

• Laparoscopic nipple- and areola-sparing mastectomy with immediate implant, patch, and fat grafting reconstruction

  This will test whether laparoscopic nipple- and areola-sparing mastectomy with an immediate pectoral-muscle implant plus patch and same-time autologous fat grafting is safe and effective for women with early unilateral breast cancer (cT1-2N0M0).

  Recruiting Henan Cancer Hospital · Zhengzhou, Henan · NCT07037537

• Cold salt-water foot baths to prevent paclitaxel-related nerve damage

  This study tests whether taking cold salt-water or plain cold-water foot baths during paclitaxel chemotherapy can prevent or reduce chemotherapy-related peripheral nerve damage in women with breast cancer.

  Recruiting Istanbul Topkapi University · Istanbul, Uskudar · NCT06964802

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.